High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
暂无分享,去创建一个
Y. Maehara | T. Ueno | M. Sata | Y. Oda | M. Kuwano | M. Tsuneyoshi | M. Ono | A. Fotovati | S. Aishima | M. Kojiro | A. Taketomi | Y. Basaki | F. Hosoi | K. Taguchi | H. Yano | Y. Nishihara | S. Oie | Y. Maruyama | Y. Kuroda
[1] M. Kojiro,et al. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma , 1986, In Vitro Cellular & Developmental Biology.
[2] M. Kuwano,et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.
[3] N. Weigel,et al. Role of insulin‐like growth factor binding proteins in 1α,25‐dihydroxyvitamin D3‐induced growth inhibition of human prostate cancer cells , 2005, The Prostate.
[4] D. Köksal,et al. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. , 2005, Respiratory medicine.
[5] Y. Li,et al. Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. , 2004, World journal of gastroenterology.
[6] S. Twigg,et al. Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells , 2004, Cancer Research.
[7] Y. Kaneko,et al. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor , 2003, Journal of Cell Science.
[8] G. Minuk,et al. The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma , 2000, Molecular and Cellular Biochemistry.
[9] F. Manguso,et al. Increased IGF‐I : IGFBP‐3 ratio in patients with hepatocellular carcinoma , 2003, Clinical endocrinology.
[10] D. Schuppan,et al. Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis , 2003, British Journal of Cancer.
[11] K. Kajiwara,et al. CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cepsilon transcription in a human B cell line. , 2002, Archives of biochemistry and biophysics.
[12] Tomoyuki Masuda,et al. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan , 2002, Hepatology.
[13] H. Huynh,et al. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] M. Uemura,et al. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. , 2002, Cancer letters.
[15] S. Maehara,et al. Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. , 2002, Surgery.
[16] I. McCutcheon,et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.
[17] G. Ramadori,et al. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC). , 1998, Carcinogenesis.
[18] P. Newcomb,et al. Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner* , 1997, The Journal of Biological Chemistry.
[19] P. Cohen,et al. Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.
[20] R. Klemke,et al. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. , 1997, The Journal of clinical investigation.
[21] K. Shirabe,et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.
[22] J. Wands,et al. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases , 1996, Molecular and cellular biology.
[23] C T Roberts,et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.
[24] M. Kojiro,et al. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells , 1993, Hepatology.
[25] R. Rosenfeld,et al. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.
[26] L. Liotta,et al. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.
[27] S. Aust,et al. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. , 1989, The Journal of biological chemistry.
[28] M. Kojiro,et al. A NEW HUMAN PLEOMORPHIC HEPATOCELLULAR CARCINOMA CELL LINE, KYN‐2 , 1988, Acta pathologica japonica.
[29] 龍夫 村上. ヒト肝細胞癌細胞株(KIM-1)の樹立と性状 , 1984 .
[30] Y. Oshika,et al. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.